IBDEI17H ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20142,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,20142,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,20143,0)
 ;;=F03.91^^94^936^13
 ;;^UTILITY(U,$J,358.3,20143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20143,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbances,Unspec
 ;;^UTILITY(U,$J,358.3,20143,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,20143,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,20144,0)
 ;;=G31.83^^94^936^14
 ;;^UTILITY(U,$J,358.3,20144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20144,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,20144,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,20144,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,20145,0)
 ;;=F01.51^^94^936^30
 ;;^UTILITY(U,$J,358.3,20145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20145,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20145,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,20145,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,20146,0)
 ;;=F01.50^^94^936^31
 ;;^UTILITY(U,$J,358.3,20146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20146,1,3,0)
 ;;=3^Vascular Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20146,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,20146,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,20147,0)
 ;;=A81.9^^94^936^6
 ;;^UTILITY(U,$J,358.3,20147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20147,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,20147,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,20147,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,20148,0)
 ;;=A81.09^^94^936^8
 ;;^UTILITY(U,$J,358.3,20148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20148,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,20148,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,20148,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,20149,0)
 ;;=A81.00^^94^936^9
 ;;^UTILITY(U,$J,358.3,20149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20149,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,20149,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,20149,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,20150,0)
 ;;=A81.01^^94^936^10
 ;;^UTILITY(U,$J,358.3,20150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20150,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,20150,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,20150,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,20151,0)
 ;;=A81.89^^94^936^7
 ;;^UTILITY(U,$J,358.3,20151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20151,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,20151,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,20151,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,20152,0)
 ;;=A81.2^^94^936^27
 ;;^UTILITY(U,$J,358.3,20152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20152,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,20152,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,20152,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,20153,0)
 ;;=B20.^^94^936^17
 ;;^UTILITY(U,$J,358.3,20153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20153,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20153,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,20153,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,20154,0)
 ;;=B20.^^94^936^18
 ;;^UTILITY(U,$J,358.3,20154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20154,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20154,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,20154,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,20155,0)
 ;;=F10.27^^94^936^1
 ;;^UTILITY(U,$J,358.3,20155,1,0)
 ;;=^358.31IA^4^2
